Q1 2019 Holdings
Filed 2019-05-10 | 110 holdings | $310.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $79.2M | 600,000 | 25.6% |
| Alibaba Group Hldg LTD(BABA) | SPONSORED ADS | 01609W102 | $75.2M | 412,000 | 24.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $42.1M | 450,000 | 13.6% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $27.0M | 400,000 | 8.7% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $25.0M | 200,000 | 8.1% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $14.7M | 125,000 | 4.7% |
| Autolus Therapeutics PLC(AUTL) | SPONSORED ADS | 05280R100 | $14.2M | 450,000 | 4.6% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $11.6M | 400,000 | 3.7% |
| Alector Inc(ALEC) | COM | 014442107 | $4.7M | 250,000 | 1.5% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $4.6M | 200,000 | 1.5% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $3.9M | 475,000 | 1.3% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $3.7M | 300,000 | 1.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $2.2M | 200,000 | 0.7% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $334.9K | 60,240,864 | 0.1% |
| Weight Watchers Intl Inc New | COM | 948626106 | $298.6K | 14,818,300 | 0.1% |
| Moderna Inc(MRNA) | COM | 60770K107 | $101.9K | 5,006,298 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $76.8K | 1,650,000 | 0.0% |
| Nvidia Corp(NVDA) | COM | 67066G104 | $75.4K | 420,000 | 0.0% |
| Celgene Corp(CELG)Call | COM | 151020104 | $70.8K | 750,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $68.0K | 850,000 | 0.0% |
| Bank Amer Corp(BAC)Call | COM | 060505104 | $55.2K | 2,000,000 | 0.0% |
| Rubius Therapeutics Inc | COM | 78116T103 | $52.7K | 2,908,791 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $48.8K | 2,000,000 | 0.0% |
| Goldman Sachs Group Inc(GS)Call | COM | 38141G104 | $48.0K | 250,000 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $45.7K | 1,150,000 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $44.1K | 2,346,040 | 0.0% |
| General Mtrs Co(GM)Call | COM | 37045V100 | $37.1K | 1,000,000 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $36.0K | 1,658,968 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $35.4K | 2,600,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $31.6K | 1,800,000 | 0.0% |
| Inflarx NV(IFRX) | COM | N44821101 | $31.2K | 825,000 | 0.0% |
| Bristol Myers Squibb Co(BMY)Call | COM | 110122108 | $31.0K | 650,000 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $30.2K | 900,000 | 0.0% |
| NIO Inc(NIO) | SPONSORED ADS | 62914V106 | $23.5K | 4,600,000 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $21.7K | 1,750,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $19.9K | 125,000 | 0.0% |
| Medicines Co | COM | 584688105 | $19.6K | 700,000 | 0.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $19.4K | 1,400,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX)Call | COM | 64125C109 | $17.6K | 200,000 | 0.0% |
| Melco Resorts and Entmt LTD(MLCO)Call | ADR | 585464100 | $16.9K | 750,000 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $16.1K | 500,000 | 0.0% |
| American Airls Group Inc(AAL)Call | COM | 02376R102 | $15.9K | 500,000 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $15.7K | 100,000 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $15.6K | 400,000 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $15.5K | 500,000 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $14.3K | 979,275 | 0.0% |
| Kaleido Biosciences Inc(KLDO) | COM | 483347100 | $13.7K | 947,419 | 0.0% |
| Agios Pharmaceuticals Inc(AGIO)Call | COM | 00847X104 | $13.5K | 200,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $12.8K | 175,000 | 0.0% |
| Qualcomm Inc(QCOM)Call | COM | 747525103 | $11.4K | 200,000 | 0.0% |